This event is intended for clinicians, researchers and healthcare professionals. Speaker Bethlehem Mengesha, MD Adult Cardiac Imaging Fellow University of Ottawa Heart Institute Topic Imaging LVH phenotypes: In the thick of it Location Centre Foustanellas Auditorium H-2367 and virtually (Zoom). Cost...
Search
Displaying 321 - 340 of 1489
This event is intended for clinicians, researchers and healthcare professionals. Speakers Lisa Bromly MD, CCPF(AM), FCFP Focused Practice in Addiction Medicine Medical Director, TOH Substance Use Program Tali Magboo Cahill, RN MSN Advanced Practice Nurse/Program Manager Substance Use Program Topic...
2023 CCS Guidelines of Management of Patients with Long QT Syndrome
The 2023 CCS/CAIC Antiplatelet Guideline Updates: A Deeper Dive into Muddy Waters
Invasive and non-invasive characterization of coronary atherosclerotic plaque
Updates from ACC 2024
Trainee involvement in clinical research: lessons learned from the RAPTOR study
TOH Virtual Critical Care Program - Please steal our idea!
AMI Cardiogenic Shock: An Old DanGer with A New Treatment
Coronary Artery Disease in Patients with Diabetes: Current Evidence and Knowledge Gaps
Clinical Practice Update on Optimal Post Cardiac Arrest and Refractory Cardiac Arrest Patient Care
Closing the Gap in Transition and Transfer of Congenital Heart Disease Care
Cardiogenic Shock: Past, present and future
Coronary Microvascular Dysfunction - Noninvasive assessment and Clinical Implication
Beyond Traditional Risk Factors: Cardiac CTA as a Guide for Primary Prevention
The Cardiology-Oncology Referral Clinic is a specialized clinic that provides a comprehensive approach to the management of cancer patients who are at risk of or have experienced cardiac toxicities from their cancer treatments.
Cardiomyopathy is a condition which affects the ability of the heart muscle to pump effectively. There are different types of cardiomyopathy and different causes.
CardioPrevent® is a heart health program that helps people with risk factors lower their chances of developing cardiovascular disease (CVD). The program accepts individuals who are at moderate to high risk for CVD. Participation requires a referral by a physician or nurse practitioner, and results are shared with the referring physician to support the coordination of care.
This risk assessment tool will ask you questions ranging from your family history to your own personal health.
The Cardiovascular Electrophysiology team is focusing on mechanistic studies of arrhythmogenic heart disease, with the hope of developing novel therapies for cardiac arrhythmias.